"This could cause serious adverse health consequences, including hypoventilation and death," the FDA statement reads.

Philips Respironics announced that it agreed to pay over a billion dollars to settle claims stemming from the 2021 U.S.

Koninklijke Philips (NYSE: PHG) notified its customers about a possible power malfunction in its Trilogy Evo continuous ...

Philips Respironics has reached a $1.1 billion settlement over claims that people who used their CPAP and other breathing ...

Philips agreed with insurers to pay Philips 540 million euros to cover Respironics recall-related product liability claims.

The recall, which was initiated by the company in March, pertains to a software issue that can cause a possible power ...

The recalls have shaken parents whose children depend on ventilators due to health conditions that affect their breathing. Doctors and children’s advocates are asking federal officials to better ...

Shares of Philips Electronics NV surged around 47 percent in the morning trading in Amsterdam as well as around 44 percent in the ...

Philips has reached a $1 billion settlement in the U.S. related its Respironics ventilators, and backed its full-year ...

Health technology company Royal Philips agreed to resolve personal injury litigation and medical-monitoring class action ...

Philips settles Respironics litigation for $1.1B, impacting Q1 2024 net income; higher costs expected but target price ...

Royal Philips said it has reached a $1.1 billion settlement in the U.S. related its Respironics ventilators, and backed its full-year guidance. The Dutch health-technology group said Monday that ...